 HAIKOU CITY, China, Sept. 11, 2019 PRNewswire -- China Pharma Holdings, Inc. NYSE American: CPHI China Pharma, CPHI, the Company or We, an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that it has entered into a Memorandum of Understanding MOU and the Addendum with World Health Advanced Technologies, Ltd W.H.A.T. to advance the scientific success of ENERCEL on an exclusive basis in China. Chinese government has had the foresight to approve and develop the Free Trade Zone of Hainan Island. 